Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2011-07-19
2011-07-19
Kam, Chih-Min (Department: 1656)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S236100, C424S009100, C512S002000, C512S012000, C530S350000
Reexamination Certificate
active
07981432
ABSTRACT:
The invention features a polypeptide complex synthesized by bacteria of the genusClostridiathat contains the serotype E botulinum neurotoxin and five neurotoxin associated polypeptides having molecular weights of about 118, 80, 65, 40, and 18 kDa, respectively. The complex is useful in the treatment of diseases or conditions that are caused by excessive release of acetylcholine from presynaptic nerve terminals.
REFERENCES:
patent: WO 95/17904 (1995-07-01), None
Babiuk, “Broadening the approaches to developing more effective vaccines,” Vaccine, 17:1587-1595 (1999).
DasGupta et al., “Purification and amino acid composition of type E botulinum neurotoxin,” Toxicon, 21:535-545 (1983).
East et al., “Conserved structure of genes encoding components of botulinum neurotoxin complex M and the sequence of the gene coding for the nontoxic component in nonproteolyticClostridium botulinumtype F,” Current Microbiology, 29:69-77 (1994).
Fiock et al., “Studies on immunity to toxins ofClostridium botulinum. VII. Purification and detoxification of trypsin-activated type E toxin,” J. Bacteriology, 82:66-72 (1961).
Fujii et al., “The complete nucleotide sequence of the gene encoding the nontoxic component ofClostridium botulinumtype E progenitor toxin,” J. General Microbiology, 139:79-86 (1993).
Gimeniz et al., “Simplified purification method forClostridium botulinumtype E toxin,” App. Environ. Microbio., 53:2827-2830 (1987).
Hauser et al., “Organization of the botulinum neurotoxin C1 gene and its associated non-toxic protein genes inClostridium botulinumC 468,” Mol. Gen. Genet, 243:631-640 (1994).
Johnson, “Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins,” Annu. Rev. Microbiol., 53:551-575 (1999).
Kitamura et al., “Significance of 12S toxin ofClostridium botulinumtype E,” J. Bacteriology, 98:1173-1178 (1969).
Molgo et al., “Characterization of the actions of botulinum neurotoxin type E at the rat neuromuscular junction,” Acta Physiol Scand, 137:497-501 (1989).
Sakaguchi, “Colostridum BotulinumToxins,” Pharmac. Ther., 19:165-194 (1983).
Schmidt et al., “Purification of type E botulinum neurotoxin by high-performance ion exchange chromatography,” Analytical Biochem., 156:213-219 (1986).
Simpson et al., “Use of monoclonal antibodies as probes for the structure and biological activity of botulinum neurotoxin,” J. Pharm. Exp. Ther., 255(1):227-232 (1990).
Simpson et al., “Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships,” J. Pharm. Exp. Ther., 224(1):135-140 (1983).
Singh et al., “Botulinum versus tetanus neurotoxins: why is botulinum neurotoxin but not tetanus neurotoxin a food poison?” Texicon, 33(12):1541-1547 (1995).
Singh et al., “Physicochemical and immunological characterization of the type E botulinum neurotoxin binding protein purified fromClostridium botulinum,” J. Protein Chemistry, 14(1):7-18 (1995).
Somers et al., “Clostridium botulinumtypes A, B, C1, and E produce proteins with or without hemagglutinating activity: do they share common amino acid sequences and genes?” J. Protein Chemistry, 10(4):415-425 (1991).
Singh Bal Ram
Zhang Zhong
Fish & Richardson P.C.
Kam Chih-Min
University of Massachusetts
LandOfFree
Proteins within the type E botulinum neurotoxin complex does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteins within the type E botulinum neurotoxin complex, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteins within the type E botulinum neurotoxin complex will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2621750